• Article
  • Nutrition and Health
  • Inner Wellbeing

ARTICLE

Nutiani HN019™: A Trusted Solution for Children’s Immunity 

ARTICLE

  • Article
  • Nutrition and Health
  • Inner Wellbeing
Did you know that probiotics during a baby’s first 1,000 days could help build a strong immune system?
 

At birth, newborns have an underdeveloped immune system¹, and with much of it housed in the gastrointestinal (GI) tract, gut health becomes essential for supporting their immunity.

During infancy, several factors contribute to the establishment of the gut microbiota, with diet including human milk and baby milk powder considered to be key factors in shaping the gut microbiota across the lifetime². 

Consumption of specific health ingredients, such as probiotics, in sufficient quantities may help to promote the colonisation and establishment of a healthy GI microbiome and support infant immune system, which is important for long-term health benefits.

Feature Tile 1240 x 930 - HN019 Oral Health

Nutiani HN019™: Supporting Immune Health in Infants

Nutiani HN019™ has been clinically shown to provide immune support, particularly in young children. Nutiani HN019™ reduces cold and flu in young children by increasing the activity of immune cells active against infections⁴ and reducing the rates of antibiotic use⁵.

Dr James Dekker, a Probiotics Scientist at Fonterra’s Research and Development Centre (FRDC), conducted a key study during the winter in Fuyang, China, involving 192 healthy infants aged 6–12 months. Over 12 weeks, participants received one of three follow-on formula solutions: one supplemented with Nutiani HN019™, another with Nutiani HN019™, and a control group with no added probiotics. The findings highlighted the distinct advantages of Nutiani HN019™:
 

Key Research Outcomes³
  • Reduced Upper Respiratory Tract Infections: Infants consuming Nutiani HN019™ experienced fewer colds and flu episodes.
  • Zero Confirmed Infections: No viral or bacterial infections were reported in the Nutiani HN019™ group.
  • No Antibiotic or Antiviral Use: None of the infants in the Nutiani HN019™ group required medication.
  • Tolerability and Growth Support: Products containing Nutiani HN019™ and Nutiani HN001™ were well-tolerated and supported normal growth.
     
Quote
Such research gives paediatric nutrition brands the ability to provide their consumers with trust and reassurance in the product they are purchasing. 

Dr James Dekker

onterra R&D Programme Manager Nutrition and Health


Build Trust with Nutiani HN019™ 

Nutiani HN019™ empowers early-life nutrition brands to strengthen their market presence through premium product positioning or by expanding their range of paediatric and maternal offerings. Our proven health benefits are backed by highly credible scientific data, addressing core parental concerns around safety and efficacy.

Nutiani HN019™ probiotics meet stringent standards for safety, efficacy, and stability. As one of the few probiotic strains approved for use in infant and young children’s foods in China, Nutiani HN019™ boasts a well-established safety record and superior shelf-life stability, with high survival rates in powdered applications, enabling cost-effective formulations.
 

1. Stras et. Al. (2019) 

2. Lobionda et. al. (2019) 

3. Dekker et al. (2022)

4. Miller et al. (2017)

5. Dekker et al. (2017) and Sazawal et al. (2010)

STAY AHEAD

New solutions, unique benefits and emerging trends. No junk.
Please enter your first name
Please enter your last name
Please enter your company name
Please enter a valid email address
This content is exclusive to authorized users only. Please reach out to your account manager if you have any concerns

Thanks for subscribing!

Oops, something went wrong